A Prospective Clinical Utility Study Demonstrates That Physicians Use the 40-Gene Expression Profile (40-GEP) to Guide Clinical Management Decisions for Medicare-Eligible Patients With Cutaneous Squamous Cell Carcinoma (cSCC). J of Skin 2022, 6 (6), s95. https://doi.org/10.25251/skin.6.supp.95.